MRNA R&D to Revenue
Moderna · R&D to Revenue
MRNA R&D to Revenue
Latest reported161.11%period ending
MRNA FY R&D/Revenue (253.44% → 161.11%)
Latest values, visible window
High-resolution chart · PNG
MRNA r&d to revenue history
Annual fiscal periods. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | R&D to Revenue |
|---|---|
| 161.1111% | |
| 142.0131% | |
| 70.7506% | |
| 17.457% | |
| 11.2258% | |
| 170.5685% | |
| 824.3103% | |
| 336.1877% | |
| 199.4214% | |
| 253.4383% |